Cannabinoids Therapies for Parkinsons Disease | cannabisMD

Cannabinoids Therapies for Parkinsons Disease

Cannabinoids Therapies for Parkinsons

Apart from being used to treat types of cancers, epilepsy, multiple sclerosis and arthritis, cannabinoid therapy is also being used to treat those with parkinson’s disease. Cannabis when consumed is said to have therapeutic and anti-inflammatory attributes. Therefore, because parkinsons effects motor functions recieved to the brain, the use of cannabis could actually help steady tremors and slurred speech.

This paper will look at how cannabis based products can be therapeutic for parkinson’s disease and what neuroprotective effects cannabis has on the brain.

Here is the full scientific article if you wish to download it.

Cannabinoids Can Help Alleviate Symptoms of PD

Parkinson’s disease (PD) is a slow moving neurological syndrome described by a loss of dopaminergic neurons in the hippocampus region of the brain. Although numerous current test developments have suggested a treatment to PD, there isn’t really any clinically existing treatment for its cure. More and more results are indicating a prominent modulatory ability of the cannabinoid transmissioning system in the basal ganglia. Hence, application of cannabinoids as a new therapeutic site has been suggested as a potentially good therapy for PD. The parts of the endocannabinoid system are highly displayed in the neural circuit of basal ganglia where a relationship is shared by dopaminergic, glutamatergic, and GABAergic transmissioning systems.

Cannabinoid agonists such as WIN-55,212-2 have been seen in tests as having neuroprotective properties in PD, with regard to their function to stop excitotoxicity, glial triggering, and oxidative damage that causes degeneration of dopaminergic neurons. This paper has tried to find further lines of study that help with the accumulation of knowledge to better the understanding of the therapeutic benefits the cannabinoid systems has for treating PD.

Cannabinoids Can Be Therapeutic in the Treatment of PD

Plenty of studies have supported the fact that massive changes of the cannabinoid transmissioning system happens in PD. This conception has been backed up by different electrophysiological, anatomical, and pharmacological discoveries.

Therefore, pharmacological changing of this system with chemicals that specifically target separate parts of cannabinoid transmissioning might better anomalies of motor behavior and give a home for neuroprotection. The antioxidant actions of certain cannabinoid chemical compounds, which are independent of their cannabinoid receptor role also have a possibility to be advanced as a treatment for PD.

Jonathan Neilly

Registered with the British Psychological Society, breaking the taboo on mental health issues is one of the driving forces in Jonathan's life. His background in biomedicine gives him additional understanding of the factors that work together to influence the human condition.

Latest posts by Jonathan Neilly

Leave a Reply

Your email address will not be published. Required fields are marked *